3/10
09:40 am
gild
Rating for GILD
Low
Report
Rating for GILD
3/10
09:40 am
gild
Rating for GILD
Low
Report
Rating for GILD
3/10
06:07 am
gild
Gilead initiated with a Buy at Jefferies
Low
Report
Gilead initiated with a Buy at Jefferies
3/10
06:07 am
gild
Gilead initiated with a Buy at Jefferies
Low
Report
Gilead initiated with a Buy at Jefferies
3/6
11:06 am
gild
Gilead Sciences (GILD) had its "buy" rating reaffirmed by Citigroup Inc..
Low
Report
Gilead Sciences (GILD) had its "buy" rating reaffirmed by Citigroup Inc..
2/23
11:23 am
gild
Gilead Sciences (NASDAQ:GILD) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $170.00 price target on the stock.
Low
Report
Gilead Sciences (NASDAQ:GILD) had its "buy" rating reaffirmed by analysts at Needham & Company LLC. They now have a $170.00 price target on the stock.
2/23
11:13 am
gild
Rating for GILD
Low
Report
Rating for GILD
2/23
11:13 am
gild
Rating for GILD
Low
Report
Rating for GILD
2/21
06:31 am
gild
Gilead Sciences (NASDAQ:GILD) was upgraded by analysts at Barclays PLC to a "hold" rating.
Low
Report
Gilead Sciences (NASDAQ:GILD) was upgraded by analysts at Barclays PLC to a "hold" rating.
2/20
09:56 am
gild
Rating for GILD
Low
Report
Rating for GILD
2/20
09:56 am
gild
Rating for GILD
Low
Report
Rating for GILD
2/20
09:00 am
gild
Gilead Sciences (NASDAQ:GILD) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $155.00 price target on the stock.
Low
Report
Gilead Sciences (NASDAQ:GILD) is now covered by analysts at Barclays PLC. They set an "equal weight" rating and a $155.00 price target on the stock.
2/19
04:18 pm
gild
Gilead initiated with an Equal Weight at Barclays
Low
Report
Gilead initiated with an Equal Weight at Barclays
2/19
04:18 pm
gild
Gilead initiated with an Equal Weight at Barclays
Low
Report
Gilead initiated with an Equal Weight at Barclays
2/11
12:14 pm
gild
Rating for GILD
Low
Report
Rating for GILD
2/11
12:14 pm
gild
Rating for GILD
Low
Report
Rating for GILD
2/11
10:59 am
gild
Gilead Sciences (NASDAQ:GILD) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.
Low
Report
Gilead Sciences (NASDAQ:GILD) had its "outperform" rating reaffirmed by analysts at Sanford C. Bernstein.
2/11
09:56 am
gild
Rating for GILD
Low
Report
Rating for GILD
2/11
09:56 am
gild
Rating for GILD
Low
Report
Rating for GILD
2/11
08:42 am
gild
Rating for GILD
Medium
Report
Rating for GILD
2/11
08:27 am
gild
Rating for GILD
Medium
Report
Rating for GILD
2/11
08:27 am
gild
Rating for GILD
Medium
Report
Rating for GILD
2/11
07:01 am
gild
Rating for GILD
Medium
Report
Rating for GILD
2/11
07:01 am
gild
Rating for GILD
Medium
Report
Rating for GILD
1/27
09:44 am
gild
Rating for GILD
Low
Report
Rating for GILD